Loading...
Derniers dépôts
-
-
S K Mahil, M Yates, S M Langan, Z Z N Yiu, T Tsakok, et al.. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*. British Journal of Dermatology, 2020, 185, pp.80 - 90. ⟨10.1111/bjd.19755⟩. ⟨hal-04953301⟩
-
Satveer K Mahil, Nick Dand, Kayleigh J Mason, Zenas Z N Yiu, Teresa Tsakok, et al.. Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study. Journal of Allergy and Clinical Immunology, 2021, 147, pp.60 - 71. ⟨10.1016/j.jaci.2020.10.007⟩. ⟨hal-04953300⟩
-
-
Sabine Blouquit-Laye, Luc Dannhoffer, Camille Braun, Anh-Tuan Dinh-Xuan, Edouard Sage, et al.. Effect of nitric oxide on epithelial ion transports in noncystic fibrosis and cystic fibrosis human proximal and distal airways. American Journal of Physiology - Lung Cellular and Molecular Physiology, 2012, 303 (7), pp.L617-L625. ⟨10.1152/ajplung.00368.2011⟩. ⟨hal-04953028⟩
-
-
-
Camille Braun, Pauline Azzano, Florence Gingras-Lessard, Émilie Roy, Kathryn Samaan, et al.. Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI): protocol for a phase 2a randomized controlled trial. Frontiers in Medicine, 2023, 10, ⟨10.3389/fmed.2023.1198173⟩. ⟨hal-04946312⟩
-
-
Camille Braun, Kathryn Samaan, François Graham, Louis Paradis, Anne Des Roches, et al.. Delayed‐type hypersensitivity gastrointestinal symptoms induced by food oral immunotherapy and efficiently treated by dupilumab: A case report. Pediatric Allergy and Immunology, 2023, 34 (3), ⟨10.1111/pai.13935⟩. ⟨hal-04946511⟩
-
-
-
-
Vijaykumar Patra, Johanna Strobl, Denise Atzmüller, Bärbel Reininger, Lisa Kleissl, et al.. Accumulation of Cytotoxic Skin Resident Memory T Cells and Increased Expression of IL-15 in Lesional Skin of Polymorphic Light Eruption. Frontiers in Medicine, 2022, 9 (5), pp.1194-1208. ⟨10.3389/fmed.2022.908047⟩. ⟨hal-04952116⟩
-
Nombre de notices
2 174
Nombre de documents
1 626
Répartition par type de documents
Evolution
Dernières publications
-
-
Fahd Al Qureshah, Jérémie Le Pen, Nicole de Weerd, Marcela Moncada-Velez, Marie Materna, et al.. A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity. Journal of Experimental Medicine, 2025, 222 (2), pp.e20241413. ⟨10.1084/jem.20241413⟩. ⟨hal-04926027⟩
-
Carla Saade, Timothée Bruel, Lou-Léna Vrignaud, Martin Killian, Annabelle Drouillard, et al.. BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals. iScience, In press, pp.111962. ⟨10.1016/j.isci.2025.111962⟩. ⟨hal-04941427⟩
-
Adriana Traore, Kelly Charniga, Sophie Grellet, Garance Terpant, Héléna da Cruz, et al.. Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024. Eurosurveillance, 2025, 30 (1), pp.1192-1194. ⟨10.2807/1560-7917.ES.2025.30.1.2400293⟩. ⟨hal-04895964⟩
-
-
Maria Scaturro, Alessio Lanni, Fabiola Mancini, Antonietta Girolamo, Silvia Fillo, et al.. Antimicrobial susceptibility and epidemiological types of Legionella pneumophila human isolates from Italy (1987–2020). Journal of Global Antimicrobial Resistance, 2025, 41, pp.181 - 188. ⟨10.1016/j.jgar.2024.12.030⟩. ⟨hal-04928690⟩
-
-
-
-
Veronica Nuccetelli, Makram Mghezzi-Habellah, Séverine Deymier, Armelle Roisin, Francine Gérard-Baraggia, et al.. The SARS-CoV-2 nucleocapsid protein interferes with the full enzymatic activation of UPF1 and its interaction with UPF2. Nucleic Acids Research, 2025, 53 (2), pp.gkaf010. ⟨10.1093/nar/gkaf010⟩. ⟨hal-04913926⟩